ミシガン州におけるがん（全種類）の臨床試験
ミシガン州内の拠点で、がん（全種類）に関する74件の研究が参加者を募集しています。
ミシガン州内の都市
- Detroit29件の研究
- Grand Rapids28件の研究
- Ann Arbor25件の研究
- Lansing6件の研究
- Flint5件の研究
- Kalamazoo3件の研究
- Waterford3件の研究
- Warren3件の研究
公式研究テキスト（英語）
A Clinical Study of Calderasib (MK-1084) in People With Advanced Solid Tumors (MK-1084-014)
- START Midwest ( Site 1103), Grand Rapids
被験者募集中第2相
18歳以上 · 全性別 · 2026/10/01更新 · NCT07209111A Study of ASP3082 in Adults With Advanced Solid Tumors
- Trinity Health Ann Arbor Hospital, Ypsilanti
被験者募集中第1相
18歳以上 · 全性別 · 2026/09/30更新 · NCT05382559A Study to Evaluate Adverse Events, Change in Disease Activity, Tolerability, and How Intravenous ABBV-438 Moves Through the Body in Adult Participants With Multiple Myeloma (MM)
- START Midwest /ID# 279035, Grand Rapids
被験者募集中第1相
18歳以上 · 全性別 · 2026/09/29更新 · NCT07409246REC-7735 in Participants With Solid Tumors
- START Midwest, Grand Rapids
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/09/29更新 · NCT07819136uTRACT Jelmyto Registry: A Registry of Patients With Upper Tract Urothelial Cancer (UTUC) Treated With Jelmyto
- University of Michigan, Ann Arbor
被験者募集中観察研究
18歳以上 · 全性別 · 2026/09/29更新 · NCT05874921Registry Study for Radiation Therapy Outcomes
- McLaren Proton Therapy Center, Flint
被験者募集中観察研究
全年齢 · 全性別 · 2026/09/29更新 · NCT01255748A Study of Ifinatamab Deruxtecan in Pediatric Participants With Relapsed or Refractory Solid Tumors (MK-9999-01D/LIGHTBEAM-U01)
- Corewell Health ( Site 4001), Grand Rapids
被験者募集中第1/2相
1 Month – 17 Years · 全性別 · 2026/09/25更新 · NCT07630974A Study of JNJ-88549968 for the Treatment of Calreticulin (CALR)-Mutated Myeloproliferative Neoplasms
- University of Michigan, Ann Arbor
- Start Midwest, Grand Rapids
被験者募集中第1相
18歳以上 · 全性別 · 2026/09/25更新 · NCT06150157A Study of JNJ-87890387 for Advanced Solid Tumors
- Start Midwest, Grand Rapids
被験者募集中第1相
18歳以上 · 全性別 · 2026/09/25更新 · NCT06178614A Study of Zolbetuximab Together With Pembrolizumab and Chemotherapy in Adults With Gastric Cancer
- University of Michigan Health System, Ann Arbor
- Barbara Ann Karmanos Cancer Center, Detroit
- Henry Ford Cancer Institute-Henry Ford Hospital, Detroit
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/24更新 · NCT06901531Pivotal Open-label Phase 3 Clinical Study of QTX-2101 in Adult Patients With Acute Promyelocytic Leukemia
- Quetzal Site 22, Ann Arbor
被験者募集中第3相
18歳〜71歳 · 全性別 · 2026/09/23更新 · NCT07504458Extension Study for Participants in Studies That Include Belzutifan (MK-6482-043/LITESPARK-043)
- Karmanos Cancer Center ( Site 0108), Detroit
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/23更新 · NCT07405164A Study to Evaluate Adverse Events and Change in Disease Activity of Intravenous ABBV-706 Versus Standard of Care in Adult Participants With Relapsed/Refractory Small Cell Lung Cancer
- Cancer And Hematology Centers Of Western Michigan - Grand Rapids /ID# 279955, Grand Rapids
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/23更新 · NCT07365241Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
- START Midwest, Grand Rapids
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/09/22更新 · NCT06128551TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
- Trinity Health Ann Arbor Hospital, Ann Arbor
- Henry Ford Health Saint John Hospital, Detroit
- Genesys Hurley Cancer Institute, Flint
- 他7件
被験者募集中第2相
12歳以上 · 全性別 · 2026/09/22更新 · NCT02693535Support for Bereaved Cancer Caregivers
- Michigan State University College of Nursing, East Lansing
被験者募集中健康なボランティア歓迎
18歳以上 · 全性別 · 2026/09/18更新 · NCT06662409Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells
- University Of Michigan Comprehensive Cancer Center, Ann Arbor
- Karmanos Cancer Center Wayne State University, Detroit
被験者募集中第2/3相
全年齢 · 全性別 · 2026/09/18更新 · NCT03435796Connect for Cancer Prevention Study (Connect)
- Henry Ford Health Systems, Detroit
被験者募集中観察研究健康なボランティア歓迎
30歳〜70歳 · 全性別 · 2026/09/17更新 · NCT04609072A Study of Patritumab Deruxtecan in Pediatric Participants With Relapsed or Refractory Solid Tumors (MK-9999-01C/LIGHTBEAM-U01)
- Corewell Health ( Site 3001), Grand Rapids
被験者募集中第1/2相
1 Month – 17 Years · 全性別 · 2026/09/17更新 · NCT06941272A Study to Investigate the Safety and Preliminary Efficacy of GSK5460025 Alone or in Combination With Other Anti-cancer Agents in Participants With Solid Tumors
- GSK Investigational Site, Detroit
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/09/16更新 · NCT07213609RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses
- University of Michigan, Ann Arbor
- Henry Ford Health, Novi
被験者募集中第2相
18歳〜80歳 · 全性別 · 2026/09/15更新 · NCT07002034A Study to Assess Adverse Events and Change in Disease Activity of Oral Surzetoclax Alone or in Combination With Subcutaneous and/or Oral Antimyeloma Agents in Adult Participants With Multiple Myeloma (MM)
- University of Michigan Health System - Ann Arbor /ID# 271536, Ann Arbor
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/09/14更新 · NCT06953960A Phase 1/1b Study of IAM1363 in HER2 Cancers
- University of Michigan, Ann Arbor
- Henry Ford Cancer Institute, Detroit
- START - Midwest Cancer Research Center, Grand Rapids
被験者募集中第1相
18歳以上 · 全性別 · 2026/09/09更新 · NCT06253871Study of Abemaciclib and Elacestrant in Participants With Brain Metastasis Due to ER+/HER-2- Breast Cancer
- Henry Ford Hospital, Detroit
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/09/09更新 · NCT05386108A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
- University of Michigan, Ann Arbor
- The Cancer & Hematology Centers, Grand Rapids
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/08更新 · NCT06119581Study of Sotorasib, Panitumumab and FOLFIRI Versus FOLFIRI With or Without Bevacizumab-awwb in Treatment-naïve Participants With Metastatic Colorectal Cancer With KRAS p.G12C Mutation
- Cancer and Hematology Centers of Western Michigan, Grand Rapids
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/03更新 · NCT06252649A Longitudinal Multi-Omic Biomarker Profiling Study of Patients With Head & Neck Squamous Cell Carcinoma (HNSCC)
- Henry Ford, Detriot
- Karmanos Cancer Institute, Detroit
被験者募集中観察研究
18歳以上 · 全性別 · 2026/09/03更新 · NCT06163534Lurbinectedin in FET-Fused Tumors
- University of Michigan, Ann Arbor
被験者募集中第1/2相
10歳以上 · 全性別 · 2026/09/02更新 · NCT05918640Prostate Active Surveillance Study
- University of Michigan, Ann Arbor
被験者募集中観察研究
21歳以上 · 男性 · 2026/09/02更新 · NCT00756665A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Anti-tumor Activity of CBI-1214 T Cell Engager in Participants With Advanced or Metastatic MSS/MSI-L Colorectal Cancer
- START Midwest, Grand Rapids
被験者募集中第1相
18歳以上 · 全性別 · 2026/08/26更新 · NCT07321106Project: Every Child for Younger Patients With Cancer
- C S Mott Children's Hospital, Ann Arbor
- Bronson Battle Creek, Battle Creek
- Children's Hospital of Michigan, Detroit
- 他14件
被験者募集中観察研究
25歳以下 · 全性別 · 2026/08/25更新 · NCT02402244Abatacept in Immune Checkpoint Inhibitor Myocarditis
- University of Michigan, Ann Arbor
被験者募集中第3相
18歳以上 · 全性別 · 2026/08/20更新 · NCT05335928Two Part Study of Nenocorilant Combined With Nivolumab in Patients With Advanced Solid Malignancies
- Site 04, Grand Rapids
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/08/19更新 · NCT07276373A Clinical Trial to Assess COM503 in Participants With Advanced Solid Malignancies
- START Midwest, Grand Rapids
被験者募集中第1相
18歳以上 · 全性別 · 2026/08/12更新 · NCT06759649A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors
- Karmanos Cancer Institute, Detroit
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/08/11更新 · NCT05592626A Study of mRNA-4106 or mRNA-4200 Administered Alone or in Combination With Anti-Cancer Agents in Participants With Solid Tumors
- START Midwest, Grand Rapids
被験者募集中第1相
18歳以上 · 全性別 · 2026/08/10更新 · NCT06880549A Master Protocol (LY900023) That Includes Several Clinical Trials of Drugs for Children and Young Adults With Cancer
- C.S. Mott Children's Hospital, Ann Arbor
被験者募集中第2相
1歳〜39歳 · 全性別 · 2026/08/07更新 · NCT05999994Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
- MyMichigan Medical Center Gratiot, Alma
- MyMichigan Medical Center Alpena, Alpena
- Trinity Health Saint Joseph Mercy Hospital Ann Arbor, Ann Arbor
- 他49件
被験者募集中第3相
18歳以上 · 全性別 · 2026/08/07更新 · NCT06580314A Study of [18F]LY4214835 in Healthy Volunteers and Participants With Cancer
- BAMF Health Inc., Grand Rapids
被験者募集中第1相健康なボランティア歓迎
18歳以上 · 全性別 · 2026/08/06更新 · NCT07258836Ask Questions About Clinical Trials
- Karmanos Cancer Institute at McLaren Bay Region, Bay City
- Karmanos Cancer Institute at McLaren Clarkston, Clarkston
- Karmanos Cancer Institute at McLaren Greater Lansing, Lansing
- 他5件
被験者募集中
18歳以上 · 全性別 · 2026/08/06更新 · NCT07343297ClinicalTrials.govより、2026/10/05時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。